133 related articles for article (PubMed ID: 19639558)
1. Balancing inflammatory, lipid, and xenobiotic signaling pathways by VSL#3, a biotherapeutic agent, in the treatment of inflammatory bowel disease.
Reiff C; Delday M; Rucklidge G; Reid M; Duncan G; Wohlgemuth S; Hörmannsperger G; Loh G; Blaut M; Collie-Duguid E; Haller D; Kelly D
Inflamm Bowel Dis; 2009 Nov; 15(11):1721-36. PubMed ID: 19639558
[TBL] [Abstract][Full Text] [Related]
2. Posttranslational inhibition of proinflammatory chemokine secretion in intestinal epithelial cells: implications for specific IBD indications.
Hörmannsperger G; Clavel T; Hoffmann M; Reiff C; Kelly D; Loh G; Blaut M; Hölzlwimmer G; Haller D
J Clin Gastroenterol; 2010 Sep; 44 Suppl 1():S10-5. PubMed ID: 20562631
[TBL] [Abstract][Full Text] [Related]
3. Changes in colon gene expression associated with increased colon inflammation in interleukin-10 gene-deficient mice inoculated with Enterococcus species.
Barnett MP; McNabb WC; Cookson AL; Zhu S; Davy M; Knoch B; Nones K; Hodgkinson AJ; Roy NC
BMC Immunol; 2010 Jul; 11():39. PubMed ID: 20630110
[TBL] [Abstract][Full Text] [Related]
4. Impact of inflammatory signaling on radiation biodosimetry: mouse model of inflammatory bowel disease.
Mukherjee S; Laiakis EC; Fornace AJ; Amundson SA
BMC Genomics; 2019 May; 20(1):329. PubMed ID: 31046668
[TBL] [Abstract][Full Text] [Related]
5. Modulation of immunity and inflammatory gene expression in the gut, in inflammatory diseases of the gut and in the liver by probiotics.
Plaza-Diaz J; Gomez-Llorente C; Fontana L; Gil A
World J Gastroenterol; 2014 Nov; 20(42):15632-49. PubMed ID: 25400447
[TBL] [Abstract][Full Text] [Related]
6. Human adipose-derived stem cells attenuate inflammatory bowel disease in IL-10 knockout mice.
Jung WY; Kang JH; Kim KG; Kim HS; Jang BI; Park YH; Song IH
Tissue Cell; 2015 Feb; 47(1):86-93. PubMed ID: 25544730
[TBL] [Abstract][Full Text] [Related]
7. The Probiotic Mixture VSL#3 Has Differential Effects on Intestinal Immune Parameters in Healthy Female BALB/c and C57BL/6 Mice.
Mariman R; Tielen F; Koning F; Nagelkerken L
J Nutr; 2015 Jun; 145(6):1354-61. PubMed ID: 25948785
[TBL] [Abstract][Full Text] [Related]
8. Inflammatory bowel disease: lessons from the IL-10 gene-deficient mouse.
Madsen KL
Clin Invest Med; 2001 Oct; 24(5):250-7. PubMed ID: 11603509
[TBL] [Abstract][Full Text] [Related]
9. Dietary arachidonic acid-mediated effects on colon inflammation using transcriptome analysis.
Knoch B; Barnett MP; McNabb WC; Zhu S; Park ZA; Khan A; Roy NC
Mol Nutr Food Res; 2010 May; 54 Suppl 1():S62-74. PubMed ID: 20440721
[TBL] [Abstract][Full Text] [Related]
10. Changes in composition of caecal microbiota associated with increased colon inflammation in interleukin-10 gene-deficient mice inoculated with Enterococcus species.
Bassett SA; Young W; Barnett MP; Cookson AL; McNabb WC; Roy NC
Nutrients; 2015 Mar; 7(3):1798-816. PubMed ID: 25768951
[TBL] [Abstract][Full Text] [Related]
11. Defective IL10 signaling defining a subgroup of patients with inflammatory bowel disease.
Begue B; Verdier J; Rieux-Laucat F; Goulet O; Morali A; Canioni D; Hugot JP; Daussy C; Verkarre V; Pigneur B; Fischer A; Klein C; Cerf-Bensussan N; Ruemmele FM
Am J Gastroenterol; 2011 Aug; 106(8):1544-55. PubMed ID: 21519361
[TBL] [Abstract][Full Text] [Related]
12. Nutrigenomics applied to an animal model of Inflammatory Bowel Diseases: transcriptomic analysis of the effects of eicosapentaenoic acid- and arachidonic acid-enriched diets.
Roy N; Barnett M; Knoch B; Dommels Y; McNabb W
Mutat Res; 2007 Sep; 622(1-2):103-16. PubMed ID: 17574631
[TBL] [Abstract][Full Text] [Related]
13. IL-25 downregulates Th1/Th17 immune response in an IL-10-dependent manner in inflammatory bowel disease.
Su J; Chen T; Ji XY; Liu C; Yadav PK; Wu R; Yang P; Liu Z
Inflamm Bowel Dis; 2013; 19(4):720-8. PubMed ID: 23429464
[TBL] [Abstract][Full Text] [Related]
14. Lactococcus lactis subsp. cremoris FC alleviates symptoms of colitis induced by dextran sulfate sodium in mice.
Nishitani Y; Tanoue T; Yamada K; Ishida T; Yoshida M; Azuma T; Mizuno M
Int Immunopharmacol; 2009 Nov; 9(12):1444-51. PubMed ID: 19733697
[TBL] [Abstract][Full Text] [Related]
15. Effects of Lactobacillus salivarius 433118 on intestinal inflammation, immunity status and in vitro colon function in two mouse models of inflammatory bowel disease.
Feighery LM; Smith P; O'Mahony L; Fallon PG; Brayden DJ
Dig Dis Sci; 2008 Sep; 53(9):2495-506. PubMed ID: 18157694
[TBL] [Abstract][Full Text] [Related]
16. The effects of dietary curcumin and rutin on colonic inflammation and gene expression in multidrug resistance gene-deficient (mdr1a-/-) mice, a model of inflammatory bowel diseases.
Nones K; Dommels YE; Martell S; Butts C; McNabb WC; Park ZA; Zhu S; Hedderley D; Barnett MP; Roy NC
Br J Nutr; 2009 Jan; 101(2):169-81. PubMed ID: 18761777
[TBL] [Abstract][Full Text] [Related]
17. Meeting summary: Signal transduction pathways in immune and inflammatory cells. November 30-December 3, 2000, Amelia Island, Florida, U.S.A.
Plevy S; Mayer L
Inflamm Bowel Dis; 2003 Jan; 9(1):28-33. PubMed ID: 12656135
[TBL] [Abstract][Full Text] [Related]
18. Antigen-presenting cells exposed to Lactobacillus acidophilus NCFM, Bifidobacterium bifidum BI-98, and BI-504 reduce regulatory T cell activity.
Schmidt EG; Claesson MH; Jensen SS; Ravn P; Kristensen NN
Inflamm Bowel Dis; 2010 Mar; 16(3):390-400. PubMed ID: 19714743
[TBL] [Abstract][Full Text] [Related]
19. Gene expression profiling identifies mechanisms of protection to recurrent trinitrobenzene sulfonic acid colitis mediated by probiotics.
Mariman R; Kremer B; van Erk M; Lagerweij T; Koning F; Nagelkerken L
Inflamm Bowel Dis; 2012 Aug; 18(8):1424-33. PubMed ID: 22162025
[TBL] [Abstract][Full Text] [Related]
20. Effects of the probiotic formulation VSL#3 on colitis in weanling rats.
Fitzpatrick LR; Hertzog KL; Quatse AL; Koltun WA; Small JS; Vrana K
J Pediatr Gastroenterol Nutr; 2007 May; 44(5):561-70. PubMed ID: 17460487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
